CARFILZOMIB and PYREXIA

Overview

PYREXIA is the #7 most commonly reported adverse reaction for CARFILZOMIB, manufactured by Onyx Pharmaceuticals, Inc.. There are 1,147 FDA adverse event reports linking CARFILZOMIB to PYREXIA. This represents approximately 2.5% of all 45,655 adverse event reports for this drug.

Patients taking CARFILZOMIB who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for CARFILZOMIB, but still significant enough to appear in the safety profile.

Other Side Effects of CARFILZOMIB

In addition to pyrexia, the following adverse reactions have been reported for CARFILZOMIB:

• PLASMA CELL MYELOMA — 2,946 reports
• OFF LABEL USE — 2,294 reports
• DEATH — 1,740 reports
• FATIGUE — 1,506 reports
• THROMBOCYTOPENIA — 1,473 reports
• PNEUMONIA — 1,340 reports
• DYSPNOEA — 1,098 reports
• DIARRHOEA — 1,091 reports
• ANAEMIA — 1,075 reports
• NEUTROPENIA — 1,059 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does CARFILZOMIB cause PYREXIA?

PYREXIA has been reported as an adverse event in 1,147 FDA reports for CARFILZOMIB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with CARFILZOMIB?

PYREXIA accounts for approximately 2.5% of all adverse event reports for CARFILZOMIB, making it a notable side effect.

What should I do if I experience PYREXIA while taking CARFILZOMIB?

If you experience pyrexia while taking CARFILZOMIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages